“IA FOR EARLY DIAGNOSIS AND TREATMENT OF DISEASES WITH HIGH PREVALENCE IN AGING”.
Program: Artificial Intelligence R&D Missions Program
Reference: MIA.2021.M02.0007
Date of RESOLUTION: 16/12/2021
Date of execution: 03/08/2021-31/12/2024
The objective of the project is the research and development of a decentralized intelligent data collection and analysis system that will enable our healthcare system to anticipate and act early and ultra-rapidly on highly prevalent psychiatric, neurological, motor and degenerative diseases in the context of aging.
Through the intelligent system, an early prognosis will be made during the follow-up of the patient with heart failure and stroke, thanks to the design and construction of Artificial Intelligence (AI) algorithms. One of the challenges facing the consortium lies in the cumulative comorbidity burden and complex clinical management.
In addition, this AI system will serve as a decision support for elderly patients with heart failure and/or stroke. Other diseases such as sarcopenia, Parkinson’s disease and hearing loss, among others, will also be analyzed as part of the project.
Project framed in the call 2021 R&D Missions in Artificial Intelligence, funded by the Recovery, Transformation and Resilience Plan within the framework of the Agenda España Digital 2025.
